These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36425583)

  • 41. Effects of valproate on acylcarnitines in children with epilepsy using ESI-MS/MS.
    Werner T; Treiss I; Kohlmueller D; Mehlem P; Teich M; Longin E; Gerstner T; Koenig SA; Schulze A
    Epilepsia; 2007 Jan; 48(1):72-6. PubMed ID: 17241210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination of lipid metabolism alterations and their sensitivity to inflammatory cytokines in human lipin-1-deficient myoblasts.
    Michot C; Mamoune A; Vamecq J; Viou MT; Hsieh LS; Testet E; Lainé J; Hubert L; Dessein AF; Fontaine M; Ottolenghi C; Fouillen L; Nadra K; Blanc E; Bastin J; Candon S; Pende M; Munnich A; Smahi A; Djouadi F; Carman GM; Romero N; de Keyzer Y; de Lonlay P
    Biochim Biophys Acta; 2013 Dec; 1832(12):2103-14. PubMed ID: 23928362
    [TBL] [Abstract][Full Text] [Related]  

  • 43. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
    Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction.
    van Breda SGJ; Claessen SMH; van Herwijnen M; Theunissen DHJ; Jennen DGJ; de Kok TMCM; Kleinjans JCS
    Toxicology; 2018 Jan; 393():160-170. PubMed ID: 29154799
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absence of spontaneous peroxisome proliferation in enoyl-CoA Hydratase/L-3-hydroxyacyl-CoA dehydrogenase-deficient mouse liver. Further support for the role of fatty acyl CoA oxidase in PPARalpha ligand metabolism.
    Qi C; Zhu Y; Pan J; Usuda N; Maeda N; Yeldandi AV; Rao MS; Hashimoto T; Reddy JK
    J Biol Chem; 1999 May; 274(22):15775-80. PubMed ID: 10336479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impaired fatty acid oxidation in children on valproic acid and the effect of L-carnitine.
    Kossak BD; Schmidt-Sommerfeld E; Schoeller DA; Rinaldo P; Penn D; Tonsgard JH
    Neurology; 1993 Nov; 43(11):2362-8. PubMed ID: 8232957
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Valproic acid I: time course of lipid peroxidation biomarkers, liver toxicity, and valproic acid metabolite levels in rats.
    Tong V; Teng XW; Chang TK; Abbott FS
    Toxicol Sci; 2005 Aug; 86(2):427-35. PubMed ID: 15858223
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
    Mirza R; Sharma B
    Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hexafluoropropylene oxide dimer acid (HFPO-DA) induced developmental cardiotoxicity and hepatotoxicity in hatchling chickens: Roles of peroxisome proliferator activated receptor alpha.
    Xu X; Ni H; Guo Y; Lin Y; Ji J; Jin C; Yuan F; Feng M; Ji N; Zheng Y; Jiang Q
    Environ Pollut; 2021 Dec; 290():118112. PubMed ID: 34500398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Argan oil prevents down-regulation induced by endotoxin on liver fatty acid oxidation and gluconeogenesis and on peroxisome proliferator-activated receptor gamma coactivator-1α, (PGC-1α), peroxisome proliferator-activated receptor α (PPARα) and estrogen related receptor α (ERRα).
    El Kebbaj R; Andreoletti P; El Hajj HI; El Kharrassi Y; Vamecq J; Mandard S; Saih FE; Latruffe N; El Kebbaj MS; Lizard G; Nasser B; Cherkaoui-Malki M
    Biochim Open; 2015; 1():51-59. PubMed ID: 29632829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peroxisome proliferator-activated receptor alpha induction of uncoupling protein 2 protects against acetaminophen-induced liver toxicity.
    Patterson AD; Shah YM; Matsubara T; Krausz KW; Gonzalez FJ
    Hepatology; 2012 Jul; 56(1):281-90. PubMed ID: 22318764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Study of Valproic Acid-Enhanced Hepatocyte Steatosis.
    Chang R; Chou MC; Hung LY; Wang ME; Hsu MC; Chiu CH
    Biomed Res Int; 2016; 2016():9576503. PubMed ID: 27034954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human urinary metabolomic profile of PPARalpha induced fatty acid beta-oxidation.
    Patterson AD; Slanar O; Krausz KW; Li F; Höfer CC; Perlík F; Gonzalez FJ; Idle JR
    J Proteome Res; 2009 Sep; 8(9):4293-300. PubMed ID: 19569716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peroxisome proliferator activated receptor alpha (PPARalpha) and PPAR gamma coactivator (PGC-1alpha) induce carnitine palmitoyltransferase IA (CPT-1A) via independent gene elements.
    Song S; Attia RR; Connaughton S; Niesen MI; Ness GC; Elam MB; Hori RT; Cook GA; Park EA
    Mol Cell Endocrinol; 2010 Aug; 325(1-2):54-63. PubMed ID: 20638986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carnitine supplementation attenuates myocardial lipid accumulation in long-chain acyl-CoA dehydrogenase knockout mice.
    Bakermans AJ; van Weeghel M; Denis S; Nicolay K; Prompers JJ; Houten SM
    J Inherit Metab Dis; 2013 Nov; 36(6):973-81. PubMed ID: 23563854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Downregulation of fatty acid oxidation by involvement of HIF-1α and PPARγ in human gastric adenocarcinoma and related clinical significance.
    Ezzeddini R; Taghikhani M; Salek Farrokhi A; Somi MH; Samadi N; Esfahani A; Rasaee MJ
    J Physiol Biochem; 2021 May; 77(2):249-260. PubMed ID: 33730333
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients.
    Goto S; Seo T; Hagiwara T; Ueda K; Yamauchi T; Nagata S; Ando Y; Ishitsu T; Nakagawa K
    J Pharm Pharmacol; 2008 Feb; 60(2):267-72. PubMed ID: 18237476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Taurine attenuates valproic acid-induced hepatotoxicity via modulation of RIPK1/RIPK3/MLKL-mediated necroptosis signaling in mice.
    Khodayar MJ; Kalantari H; Khorsandi L; Ahangar N; Samimi A; Alidadi H
    Mol Biol Rep; 2021 May; 48(5):4153-4162. PubMed ID: 34032977
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced adiposity and liver steatosis by stearoyl-CoA desaturase deficiency are independent of peroxisome proliferator-activated receptor-alpha.
    Miyazaki M; Dobrzyn A; Sampath H; Lee SH; Man WC; Chu K; Peters JM; Gonzalez FJ; Ntambi JM
    J Biol Chem; 2004 Aug; 279(33):35017-24. PubMed ID: 15180999
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatotoxicity in rat following administration of valproic acid.
    Sugimoto T; Woo M; Nishida N; Takeuchi T; Sakane Y; Kobayashi Y
    Epilepsia; 1987; 28(2):142-6. PubMed ID: 3102219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.